Persistent LCMV infection is controlled by blockade of type I interferon signaling

JR Teijaro, C Ng, AM Lee, BM Sullivan, KCF Sheehan… - Science, 2013 - science.org
Science, 2013science.org
During persistent viral infections, chronic immune activation, negative immune regulator
expression, an elevated interferon signature, and lymphoid tissue destruction correlate with
disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling
using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased
expression of negative immune regulatory molecules, and restored lymphoid architecture in
mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and …
During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell–dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.
AAAS